Discovery of new MurF inhibitors via pharmacophore modeling and QSAR analysis followed by in-silico screening

Molecular Properties That Influence the Oral Bioavailability of Drug Candidates

Daniel F. Veber, Stephen R. Johnson, Hung‐Yuan Cheng et al. · Journal of Medicinal Chemistry · 2002 · 8.1K citations

Pharmacy, Pharmacokinetics, Pharmacology +15

LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites

C. M. Venkatachalam, Xiaoman Jiang, Tom Oldfield et al. · Journal of Molecular Graphics and Modelling · 2002 · 995 citations

Pharmacy, Medicinal Chemistry, Drug Design +10

THE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN)

Frederick M. Kahan, Jean S. Kahan, Patrick J. Cassidy et al. · Annals of the New York Academy of Sciences · 1974 · 786 citations

Medicine, Pharmacokinetics, Pharmacology +12

Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming

Daniel K. Gehlhaar, Gennady M. Verkhivker, Paul A. Rejto et al. · Chemistry & Biology · 1995 · 685 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +17

Antimicrobial Resistance among Clinical Isolates of <i>Streptococcus pneumoniae</i> in the United States during 1999–2000, Including a Comparison of Resistance Rates since 1994–1995

Gary V. Doern, Kristopher P. Heilmann, Holly K. Huynh et al. · Antimicrobial Agents and Chemotherapy · 2001 · 540 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14